Simplify Health Care ETF
Name
As of 10/21/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
18.3%
1 yr return
32.2%
3 Yr Avg Return
8.1%
5 Yr Avg Return
N/A
Net Assets
$106 M
Holdings in Top 10
58.0%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.50%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Name
As of 10/21/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
PINK - Profile
Distributions
- YTD Total Return 18.3%
- 3 Yr Annualized Total Return 8.1%
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio N/A
- Dividend Yield 0.2%
- Dividend Distribution Frequency Quarterly
Fund Details
-
Legal NameSimplify Health Care ETF
-
Fund Family NameN/A
-
Inception DateOct 08, 2021
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerMichael Taylor
Fund Description
Principal Investment Strategies: Under normal circumstances, the Fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The Fund defines health care companies as companies included in the Global Industry Classification Standard health care sector. The Fund defines equity securities as common stock, preferred stock, or ETFs that invest in the same. The Fund invests in companies without restriction as to capitalization, including micro-capitalization companies.
The Fund will invest in 50 to 100 health care companies. The Fund will use fundamental, bottom-up analysis that seeks to identify high-quality companies and the most compelling investment opportunities. In general, the Fund will follow a growth investment strategy, seeking companies whose earnings are expected to grow faster than inflation and the economy in general. When stock valuations seem unusually high, however, a “value” approach, which gives preference to seemingly undervalued companies, may be emphasized. The Fund generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems. The Fund may invest in health care companies that do not seek to design or develop treatments for breast cancer.
The Fund’s namesake is The Susan G. Komen Breast Cancer Foundation, Inc. (the “Foundation”), a 501(c)(3) charitable foundation. In exchange for the use of its name and logo, Simplify Asset Management Inc., the Fund’s investment adviser (the “Adviser”), will donate its annual management fee for managing the Fund to the Foundation. The Foundation shall use such donation to support its mission, but the Foundation will not participate in or have any influence on the day-to-day operations of the Fund or the Adviser’s management of the Fund. The Fund is not organized as a charitable investment trust.
PINK - Performance
Return Ranking - Trailing
Period | PINK Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 18.3% | -25.6% | 23.4% | 94.97% |
1 Yr | 32.2% | -30.0% | 21.8% | N/A |
3 Yr | 8.1%* | -18.7% | 19.7% | N/A |
5 Yr | N/A* | -14.7% | 15.3% | N/A |
10 Yr | N/A* | -6.2% | 15.7% | N/A |
* Annualized
Return Ranking - Calendar
Period | PINK Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 2.8% | -53.9% | 11.7% | N/A |
2022 | -4.8% | -22.3% | 18.5% | N/A |
2021 | N/A | -4.7% | 41.4% | N/A |
2020 | N/A | -10.2% | 13.1% | N/A |
2019 | N/A | -5.7% | 26.9% | N/A |
Total Return Ranking - Trailing
Period | PINK Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 18.3% | -41.2% | 23.4% | 94.97% |
1 Yr | 32.2% | -30.0% | 28.3% | N/A |
3 Yr | 8.1%* | -18.7% | 19.7% | N/A |
5 Yr | N/A* | -14.7% | 15.3% | N/A |
10 Yr | N/A* | -6.2% | 15.7% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | PINK Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 3.8% | -53.9% | 11.7% | N/A |
2022 | -4.4% | -22.3% | 18.5% | N/A |
2021 | N/A | -4.7% | 41.4% | N/A |
2020 | N/A | -10.2% | 13.1% | N/A |
2019 | N/A | -5.7% | 26.9% | N/A |
PINK - Holdings
Concentration Analysis
PINK | Category Low | Category High | PINK % Rank | |
---|---|---|---|---|
Net Assets | 106 M | 732 K | 46.2 B | 78.69% |
Number of Holdings | 53 | 21 | 473 | 71.20% |
Net Assets in Top 10 | 79.5 M | 2.18 K | 21.6 B | 71.20% |
Weighting of Top 10 | 57.98% | 12.3% | 80.8% | 28.80% |
Top 10 Holdings
- Sarepta Therapeutics Inc 12.03%
- Eli Lilly Co 7.53%
- FIDELITY INV MMTRSY 1 680 5.79%
- UnitedHealth Group Inc 5.01%
- Intuitive Surgical Inc 4.97%
- Regeneron Pharmaceuticals Inc 4.87%
- Merck Co Inc 4.63%
- PureCycle Technologies Inc 4.57%
- Boston Scientific Corp 4.47%
- Novo Nordisk A/S 4.10%
Asset Allocation
Weighting | Return Low | Return High | PINK % Rank | |
---|---|---|---|---|
Stocks | 95.75% | 85.37% | 106.13% | 4.71% |
Cash | 4.25% | -0.10% | 9.01% | 81.68% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 7.85% |
Other | 0.00% | -22.99% | 3.38% | 21.99% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 7.33% |
Bonds | 0.00% | 0.00% | 12.39% | 3.66% |
Stock Sector Breakdown
Weighting | Return Low | Return High | PINK % Rank | |
---|---|---|---|---|
Utilities | 0.00% | 0.00% | 0.00% | 1.05% |
Technology | 0.00% | 0.00% | 22.69% | 8.38% |
Real Estate | 0.00% | 0.00% | 7.13% | 6.28% |
Industrials | 0.00% | 0.00% | 7.02% | 6.81% |
Healthcare | 0.00% | 59.26% | 100.00% | 1.05% |
Financial Services | 0.00% | 0.00% | 1.85% | 24.08% |
Energy | 0.00% | 0.00% | 0.00% | 1.05% |
Communication Services | 0.00% | 0.00% | 9.11% | 4.71% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 12.57% |
Consumer Cyclical | 0.00% | 0.00% | 14.20% | 6.28% |
Basic Materials | 0.00% | 0.00% | 14.83% | 30.37% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | PINK % Rank | |
---|---|---|---|---|
US | 95.75% | 53.67% | 104.41% | 1.05% |
Non US | 0.00% | 0.00% | 45.40% | 94.76% |
PINK - Expenses
Operational Fees
PINK Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.50% | 0.08% | 3.13% | 76.80% |
Management Fee | 0.50% | 0.00% | 1.25% | 15.85% |
12b-1 Fee | N/A | 0.00% | 1.00% | 1.18% |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
PINK Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 0.00% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
PINK Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
PINK Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | N/A | 0.00% | 238.00% | N/A |
PINK - Distributions
Dividend Yield Analysis
PINK | Category Low | Category High | PINK % Rank | |
---|---|---|---|---|
Dividend Yield | 0.25% | 0.00% | 2.44% | 15.31% |
Dividend Distribution Analysis
PINK | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Quarterly | Annually | Quarterly | Annually |
Net Income Ratio Analysis
PINK | Category Low | Category High | PINK % Rank | |
---|---|---|---|---|
Net Income Ratio | N/A | -2.54% | 1.92% | N/A |
Capital Gain Distribution Analysis
PINK | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Sep 25, 2024 | $0.020 | OrdinaryDividend |
Jun 25, 2024 | $0.030 | OrdinaryDividend |
Mar 25, 2024 | $0.030 | OrdinaryDividend |
Dec 26, 2023 | $0.080 | OrdinaryDividend |
Sep 27, 2023 | $0.030 | OrdinaryDividend |
Jun 27, 2023 | $0.130 | OrdinaryDividend |
Mar 27, 2023 | $0.018 | OrdinaryDividend |
Dec 27, 2022 | $0.017 | OrdinaryDividend |
Sep 27, 2022 | $0.031 | OrdinaryDividend |
Jun 27, 2022 | $0.029 | OrdinaryDividend |
Mar 28, 2022 | $0.035 | OrdinaryDividend |
Dec 27, 2021 | $0.012 | OrdinaryDividend |
PINK - Fund Manager Analysis
Managers
Michael Taylor
Start Date
Tenure
Tenure Rank
Oct 07, 2021
0.65
0.7%
Michael Taylor has been a portfolio manager at the Adviser since October 2021. In addition to serving as portfolio manager, Mr. Taylor is the Managing Director and portfolio manager at Critical Mass Partners, LLC, a company that focuses health care investing since 2011.
Paul Kim
Start Date
Tenure
Tenure Rank
Oct 07, 2021
0.65
0.7%
Paul S. Kim has been with PGI since 2015. Previously, he was a senior vice president at PIMCO from 2009-2015. He earned a bachelor’s degree in Economics from Dartmouth College and an M.B.A. in Finance from The Wharton School at the University of Pennsylvania. Mr. Kim has earned the right to use the Chartered Financial Analyst designation.
David Berns
Start Date
Tenure
Tenure Rank
Oct 07, 2021
0.65
0.7%
David Berns, PhD, is the chief investment officer and co-founder of the Simplify Asset Management Inc. Prior to co-founding the Simplify Asset Management in 2020, he founded Portfolio Designer, LLC, a company that specializes in portfolio design and from 2018 to 2019 was a managing director at Nasdaq Dorsey Wright. Prior to joining Nasdaq Dorsey Wright, Inc., he founded and developed a company that specializes in proprietary trading. He has specialized in developing asset allocation, portfolio management, and risk management systems for managing private and institutional wealth. Mr. Berns has a PhD in Physics from the Massachusetts Institute of Technology in the field of Quantum Computation.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.26 | 2.12 |